Company News for June 29, 2009 – Corporate Summary
Source: http://www.zacks.com/stock/news/21560/Company+News+for+June+29%2C+2009+-+Corporate+SummaryPosted on Monday, June 29th, 2009 | In Market Commentary, Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
* FBR Capital downgraded Alcoa (NYSE:AA) to “underperform” from “market perform,” citing valuation and oversupply concerns
* According to an unidentified report of a clinical study out of Europe, insulin users of long-acting drugs showed increased cancer risks. Manufactures of such drugs include Sanofi Aventis (NYSE:SNY) and Novo Nordisk (NYSE:NVO), while Amylin (NASDAQ:AMLN) manufactures a non-insulin-based treatment
* According to news reports, Novartis (NYSE:NVS) is in talks to acquire parts of Elan (NYSE:ELN), including its multiple sclerosis drug Tysabri and its pipeline of Alzheimer’s drugs
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Tags for this Post:
Alcoa, Alzheimer's, Amylin, cancer, Elan, eln, Europe, FBR Capital;, Market Commentary, Multiple Sclerosis, Novartis, Novo Nordisk, pipeline of Alzheimer, Sanofi-Aventis;, Stocks to Watch, Tysabri, Zacks Market Commentaries
Alcoa, Alzheimer's, Amylin, cancer, Elan, eln, Europe, FBR Capital;, Market Commentary, Multiple Sclerosis, Novartis, Novo Nordisk, pipeline of Alzheimer, Sanofi-Aventis;, Stocks to Watch, Tysabri, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.